Godrej Consumer Products Limited (GODREJCP)
Press Release
Press Release - Q2FY27
- Consolidated sales grew 19% y-y with 8% volume growth; standalone sales up 13% with 7% volume growth
- Consolidated EBITDA grew 12% y-y; net profit increased 14% to ₹523 crore
- Home Care grew 19%, led by Air Fresheners and Household Insecticides market share gains
- Personal Care grew 8%, with stable soaps and double-digit growth in perfumes and deodorants
- Indonesia sales up 20% with 8% volume growth; EBITDA grew 12% despite LPG price rise
- Africa, USA, Middle East sales grew 40% (23% CC), EBITDA up 43%, with broad-based growth
- Input cost inflation high; company taking pricing actions and cost savings to maintain profit growth
- FY27 guidance maintained: high-single-digit volume growth standalone, double-digit consolidated revenue and EBITDA growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GODREJCP — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GODREJCP to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Godrej Consumer Products Limited
Important.
The summary above is generated automatically from Godrej Consumer Products Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.